These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2093541)

  • 1. Changes in red blood cell volume under recombinant human erythropoietin therapy.
    Schmidt R; Lerche D; Dörp E; Winkler R; Klinkmann H
    Contrib Nephrol; 1990; 87():52-8. PubMed ID: 2093541
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of renal anaemia with recombinant human erythropoietin results in decreased red cell uptake of 45Ca.
    Linde T; Ronquist G; Sandhagen B; Wikström B; Frithz G; Pettersson L; Danielson BG
    Nephron; 1994; 68(4):419-26. PubMed ID: 7870225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide and glutathione status in erythrocytes of children undergoing chronic hemodialysis under erythropoietin treatment.
    Sachs G; Siems W; Grune T; Schmidt G; Gerber G; Zoellner K
    Biomed Biochim Acta; 1990; 49(2-3):S123-4. PubMed ID: 2386496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin: a review.
    Ridley DM; Dawkins F; Perlin E
    J Natl Med Assoc; 1994 Feb; 86(2):129-35. PubMed ID: 8169988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Erythropoietin, blood viscosity and hypertension in chronic kidney failure].
    Schaefer RM; Heidland A
    Dtsch Med Wochenschr; 1989 Jun; 114(26):1046-9. PubMed ID: 2661190
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of human recombinant erythropoietin on the lipid peroxidation processes and antioxidant protection of the erythrocytes in patients with chronic kidney failure on hemodialysis].
    Rud'ko IA; Balashova TS; Pokrovskiĭ IuA; Ermolenko VM; Kubatiev AA
    Gematol Transfuziol; 1993 Mar; 38(3):24-6. PubMed ID: 8020730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin in the diabetic patient.
    Friedman EA; Delano BG
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):35-9. PubMed ID: 2192415
    [No Abstract]   [Full Text] [Related]  

  • 8. Determinants of red cell distribution width (RDW) in cardiorenal patients: RDW is not related to erythropoietin resistance.
    Emans ME; van der Putten K; van Rooijen KL; Kraaijenhagen RJ; Swinkels D; van Solinge WW; Cramer MJ; Doevendans PA; Braam B; Gaillard CA
    J Card Fail; 2011 Aug; 17(8):626-33. PubMed ID: 21807323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of recombinant human erythropoietin on mean corpuscular volume in patients with the anemia of chronic renal failure.
    Schwartz AB; Orquiza CS
    Clin Nephrol; 1995 Apr; 43(4):256-9. PubMed ID: 7606880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy.
    Georgatzakou HT; Tzounakas VL; Kriebardis AG; Velentzas AD; Papageorgiou EG; Voulgaridou AI; Kokkalis AC; Antonelou MH; Papassideri IS
    Eur J Haematol; 2017 Jun; 98(6):590-600. PubMed ID: 28295628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia].
    Nikolaev AIu; Klepikov PV; Lashutin SV
    Ter Arkh; 1992; 64(6):90-1. PubMed ID: 1440349
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of recombinant human erythropoietin during hemodialysis on the thrombocyte and erythrocyte functions of patients with chronic kidney failure].
    Rud'ko IA; Balashova TS; Kubatiev AA; Ermolenko VM
    Ter Arkh; 1994; 66(6):57-60. PubMed ID: 7940371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative injury to erythrocytes, cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment.
    Zachée P; Ferrant A; Daelemans R; Coolen L; Goossens W; Lins RL; Couttenye M; De Broe ME; Boogaerts MA
    Nephron; 1993; 65(2):288-93. PubMed ID: 8247195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood rheology and 2,3-diphosphoglycerate levels after erythropoietin treatment.
    Crowley JP; Chazan JA; Metzger JB; Pono L; Valeri CR
    Ann Clin Lab Sci; 1993; 23(1):24-32. PubMed ID: 8430997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in rheology and red blood cell function under recombinant human erythropoietin therapy.
    Schmidt R; Lerche D; Dörp E; Winkler R; Klinkmann H
    Pol Arch Med Wewn; 1991 Jun; 85(6):384-90. PubMed ID: 1896402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study.
    Pollok M; Bommer J; Gurland HJ; Koch KM; Schoeppe W; Scigalla P; Baldamus CA
    Contrib Nephrol; 1989; 76():201-11; discussion 212-8. PubMed ID: 2684523
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial.
    Lim VS; DeGowin RL; Zavala D; Kirchner PT; Abels R; Perry P; Fangman J
    Ann Intern Med; 1989 Jan; 110(2):108-14. PubMed ID: 2909202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of fetal hemoglobin by recombinant human erythropoietin in patients with end-stage renal disease.
    Salvati F
    Nephron; 1993; 65(2):313. PubMed ID: 7504213
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effects of recombinant human erythropoietin on circulating human hemopoietic progenitor cells.
    Ganser A; Bergmann M; Völkers B; Grützmacher P; Scigalla P; Hoelzer D
    Exp Hematol; 1989 Jun; 17(5):433-5. PubMed ID: 2714423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.